Clinical Analysis of Bloodstream Infection of Escherichia coli in Patients with Pancreatic Cancer from 2011 to 2019

Table 3

Analysis of risk factors for E. coli BSI in patients with pancreatic cancer.

Risk factor	Category	Infected group (n = 31)		Control group (n = 93)		p value
		Number of cases	Composition ratio (%)	Number of cases	Composition ratio (%)
Gender	Male	18	58.1	51	54.8	0.836
	Female	13	41.9	42	45.2
Age (years)	≥60	15	48.3	56	60.2	0.297
	<60	16	51.7	37	39.8
Hospitalization days	≥7	17	54.8	11	11.8	<0.001
	<7	14	45.2	82	88.2
Clinical stage	Late	27	87.1	74	79.6	0.432
	Early	4	12.9	19	20.4
Number of admissions (times)	≥2	30	96.8	79	84.9	0.067
	<2	1	3.2	14	15.1
Surgery	Yes	18	58.1	6	6.5	<0.001
	No	13	41.9	87	93.5
Intraoperative bleeding	Yes	6	19.4	22	23.7	0.805
	No	25	80.6	71	76.3
Chemotherapy	Yes	21	67.7	46	49.5	0.097
	No	10	32.3	47	50.5
Radiotherapy	Yes	1	3.3	0	0.0	0.250
	No	30	96.7	93	100.0
Type of antibiotics used (species)	≥2	9	29.0	12	12.9	0.052
	<2	22	71.0	81	87.1
Distant organ metastasis of cancer	Yes	16	51.6	35	37.6	0.208
	No	15	48.4	58	62.4
Central venous catheter	Yes	1	3.3	0	0.0	0.250
	No	30	96.7	93	100.0
Drainage tube	Yes	12	38.7	32	34.4	0.670
	No	19	61.3	61	65.6
Merger with other parts of infection	Yes	6	19.4	16	17.2	0.790
	No	25	80.6	77	82.8
Stayed in ICU	Yes	5	16.1	8	8.6	0.308
	No	26	83.9	85	91.4
Blood transfusion	Yes	5	16.1	18	19.4	0.795
	No	26	83.9	75	80.6
Combined with diabetes	Yes	5	16.1	25	26.9	0.333
	No	26	83.9	68	73.1
Glutamine transfusion	Yes	9	29.0	37	39.8	0.391
	No	22	71.0	56	60.2
White blood cells (/L)	<3.5 × 109	2	6.5	9	9.7	0.729
	≥3.5 × 109	29	93.5	84	90.3
Neutropenia	Yes	1	3.2	4	4.3	1.000
	No	30	96.8	89	95.7
Albumin (g/L)	<40.0	24	77.4	48	51.6	0.012
	≥40.0	7	22.6	45	48.4
Prealbumin (g/L)	<0.2	28	90.3	65	69.9	0.030
	≥0.2	3	9.7	28	30.1
Death	Yes	13	41.9	8	8.6	<0.001
	No	18	58.1	85	91.4